The hVps34-SGK3 pathway alleviates sustained PI3K/Akt inhibition by stimulating mTORC1 and tumour growth
- PMID: 27798145
- PMCID: PMC5069549
- DOI: 10.15252/embj.201670010
The hVps34-SGK3 pathway alleviates sustained PI3K/Akt inhibition by stimulating mTORC1 and tumour growth
Abstract
Erratum for
-
The hVps34-SGK3 pathway alleviates sustained PI3K/Akt inhibition by stimulating mTORC1 and tumour growth.EMBO J. 2016 Sep 1;35(17):1902-22. doi: 10.15252/embj.201693929. Epub 2016 Aug 1. EMBO J. 2016. PMID: 27481935 Free PMC article.
References
-
- Castel P, Ellis H, Bago R, Toska E, Razavi P, Carmona FJ, Kannan S, Verma CS, Dickler M, Chandarlapaty S, Brogi E, Alessi DR, Baselga J, Scaltriti M (2016) PDK1‐SGK1 signaling sustains AKT‐independent mTORC1 activation and confers resistance to PI3Kα Inhibition. Cancer Cell 30: 229–242 - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources